Navigation Links
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Date:2/27/2008

with greater ease, patient comfort and convenience.

Alexza has six product candidates in clinical development. Alexza's lead program, AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches has completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. AZ- 003 (Staccato fentanyl), which is partnered with Endo Pharmaceuticals in North America, for the treatment of breakthrough pain and AZ-007 (Staccato zaleplon) for the treatment of insomnia are in Phase 1 testing. More information, including this and past press releases from Alexza is available online at http://www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding growth of the Company's product candidate pipeline and development of the Company's product candidates. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K/A for the year ended December 31, 2006, and the Company's other Periodic and Current Reports filed with the Securities and Exch
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
2. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
3. Pharmasset Appoints Michael Rogers as Chief Development Officer
4. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
5. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
9. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
10. Royea Joins Eklin Medical Systems as VP of Worldwide Sales
11. Eric K. Rowinsky Joins ADVENTRX Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014 Research and Markets ... Market by Material, by Application, Geography - Global Analysis ... offering. Organic electronics, also called as ... material science which deals with small conductive molecules and ... small molecules and polymers are carbon based, made using ...
(Date:10/20/2014)... 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: ... a Notice of Grant Award (NGA) with the ... 1, 2014.  The NGA provides for the immediate ... of additional grant funds pursuant to the previously ... development of Asterias, product, AST-OPC1. The grant provides ...
(Date:10/20/2014)... N.J. (PRWEB) October 20, 2014 ... the Sidney Kimmel Cancer Center at Thomas Jefferson ... , Through the Strategic Alliance Partnership program, ... OncLive will collaborate to raise awareness of the ... treatment, and other projects. Clinicians and other health ...
(Date:10/19/2014)... , Oct. 19, 2014 NextCODE Health, which ... whole genome in real time, today announced the launch of ... NextCODE Exchange , at the American Society of Human Genetics ... To learn more, sign up and apply for free beta ... unique features and benefits can be viewed here . ...
Breaking Biology Technology:Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3
... Mike Byrom, Vince , Pallotta, ... 2130 Woodward Street Austin, TX 78744-1832 * Corresponding authors <A , ... href="mailto:lford@ambion.com">lford@ambion.com , ... , Labeling GAPDH and c-myc siRNA with either fluorescein ...
... Collections of siRNAs targeting , ... cells. To identify genes involved in ... cells can be transfected with different siRNAs and assayed for , ... Cellomics, Inc., who pioneered the field of High Content , ...
... Up to 50X more activity and 350% greater , catalytic efficiency ... DNA that can plague RT-PCR , ... origin: Purified from a source that is 10 7 -fold ... , , ...
Cached Biology Technology:Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 2Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 3Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 4Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 5Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 6Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 7Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 8Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 9Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 10Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 11Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 12Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 13Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 14Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 15Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect 16Using Validated siRNAs in Functional Genomic Assays 2Using Validated siRNAs in Functional Genomic Assays 3TURBO DNase: Hyperactive, Salt Tolerant DNase 2TURBO DNase: Hyperactive, Salt Tolerant DNase 3TURBO DNase: Hyperactive, Salt Tolerant DNase 4TURBO DNase: Hyperactive, Salt Tolerant DNase 5
(Date:10/19/2014)... India over the last 30 years contributed only ... during that time, according to a new study ... ., "Energy access is fundamental to development: it ... education, communication, and health," says IIASA researcher Shonali ... energy access is widely agreed to be an ...
(Date:10/17/2014)... regarding Ebola is critical and pertinent for practicing physicians ... outbreak and epidemic. The Journal, Disaster Medicine and ... Ebola Virus and Public Health, to surround the public, ... critical societal moment. , On October 17, the ... . The primer was prepared by Dr. Eric Toner, ...
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
Breaking Biology News(10 mins):Improved electricity access has little impact on climate change 2Modeling tumor dormancy 2
... When a zebra finch hears a new song from a member ... brain in unexpected ways, researchers report. The sequential switching on and ... tune offers a new picture of memory in the songbird brain. ... the National Academy of Sciences , was a surprise, said principal ...
... Institute,s Xie Lab has revealed how the BAM protein ... involved in regulating the quality of stem cells through ... Early Edition. Maintaining the proper balance between ... homeostasis. An imbalance between the two can lead to ...
... funded will serve aquaculture and papaya farmers as well ... species endangered due to attacks by several species of ... WPTRC, was awarded $186,960 for a genetic variability study ... vannamei, through developing a panel of species-specific microsatellite genetic ...
Cached Biology News:Researchers see evidence of memory in the songbird brain 2Xie Lab uncovers molecular machinery related to stem cell fate 2T-STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 2
... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...
... Antibody Plate is a 96-well ELISA-compatible ... This antibody (mouse IgG 1 ) ... glutathione-S-transferase (GST), and binds with ... fusion protein in which the tag ...
... Testing Laboratory (RTL) can provide you ... years. ,,Microbial method development and validation ... the conditions of your GMP manufacturing ... products,,We offer a full spectrum of ...
... QED Bioscience has over 23 years of ... lines. We have made antibodies to large ... and viral antigens, and plasmid DNA-encoded antigens. ... is unique, so our hybridoma development programs ...
Biology Products: